nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Thiotepa—sarcoma	0.111	0.458	CbGbCtD
Sibutramine—CYP3A4—Mitoxantrone—sarcoma	0.0477	0.197	CbGbCtD
Sibutramine—CYP3A4—Vincristine—sarcoma	0.0328	0.136	CbGbCtD
Sibutramine—CYP3A4—Etoposide—sarcoma	0.0301	0.124	CbGbCtD
Sibutramine—CYP3A4—Doxorubicin—sarcoma	0.0205	0.0847	CbGbCtD
Sibutramine—Anorexia—Etoposide—sarcoma	0.000555	0.000732	CcSEcCtD
Sibutramine—Diarrhoea—Thiotepa—sarcoma	0.000555	0.000732	CcSEcCtD
Sibutramine—Abdominal pain—Mitoxantrone—sarcoma	0.000554	0.00073	CcSEcCtD
Sibutramine—Body temperature increased—Mitoxantrone—sarcoma	0.000554	0.00073	CcSEcCtD
Sibutramine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000553	0.00073	CcSEcCtD
Sibutramine—Bronchitis—Epirubicin—sarcoma	0.000552	0.000728	CcSEcCtD
Sibutramine—Diarrhoea—Dactinomycin—sarcoma	0.000551	0.000726	CcSEcCtD
Sibutramine—Hypotension—Etoposide—sarcoma	0.000544	0.000718	CcSEcCtD
Sibutramine—Gastritis—Doxorubicin—sarcoma	0.000544	0.000718	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000542	0.000715	CcSEcCtD
Sibutramine—Muscular weakness—Doxorubicin—sarcoma	0.000542	0.000715	CcSEcCtD
Sibutramine—Dysuria—Epirubicin—sarcoma	0.000537	0.000708	CcSEcCtD
Sibutramine—Dizziness—Thiotepa—sarcoma	0.000536	0.000707	CcSEcCtD
Sibutramine—Abdominal distension—Doxorubicin—sarcoma	0.000535	0.000705	CcSEcCtD
Sibutramine—Asthma—Doxorubicin—sarcoma	0.000531	0.000701	CcSEcCtD
Sibutramine—Dysphagia—Doxorubicin—sarcoma	0.000531	0.000701	CcSEcCtD
Sibutramine—Influenza—Doxorubicin—sarcoma	0.000531	0.000701	CcSEcCtD
Sibutramine—Pollakiuria—Epirubicin—sarcoma	0.00053	0.0007	CcSEcCtD
Sibutramine—Hypersensitivity—Vincristine—sarcoma	0.00053	0.000699	CcSEcCtD
Sibutramine—Eosinophilia—Doxorubicin—sarcoma	0.000526	0.000694	CcSEcCtD
Sibutramine—Photosensitivity reaction—Epirubicin—sarcoma	0.000524	0.000691	CcSEcCtD
Sibutramine—Paraesthesia—Etoposide—sarcoma	0.000523	0.00069	CcSEcCtD
Sibutramine—Weight increased—Epirubicin—sarcoma	0.000523	0.000689	CcSEcCtD
Sibutramine—Dyspnoea—Etoposide—sarcoma	0.000519	0.000685	CcSEcCtD
Sibutramine—Hyperglycaemia—Epirubicin—sarcoma	0.000518	0.000683	CcSEcCtD
Sibutramine—Somnolence—Etoposide—sarcoma	0.000518	0.000683	CcSEcCtD
Sibutramine—Angina pectoris—Doxorubicin—sarcoma	0.000517	0.000683	CcSEcCtD
Sibutramine—Hypersensitivity—Mitoxantrone—sarcoma	0.000516	0.000681	CcSEcCtD
Sibutramine—Asthenia—Vincristine—sarcoma	0.000516	0.00068	CcSEcCtD
Sibutramine—Vomiting—Thiotepa—sarcoma	0.000516	0.00068	CcSEcCtD
Sibutramine—Pneumonia—Epirubicin—sarcoma	0.000515	0.000679	CcSEcCtD
Sibutramine—Vomiting—Dactinomycin—sarcoma	0.000512	0.000675	CcSEcCtD
Sibutramine—Rash—Thiotepa—sarcoma	0.000511	0.000674	CcSEcCtD
Sibutramine—Bronchitis—Doxorubicin—sarcoma	0.000511	0.000674	CcSEcCtD
Sibutramine—Dermatitis—Thiotepa—sarcoma	0.000511	0.000674	CcSEcCtD
Sibutramine—Headache—Thiotepa—sarcoma	0.000508	0.00067	CcSEcCtD
Sibutramine—Rash—Dactinomycin—sarcoma	0.000507	0.000669	CcSEcCtD
Sibutramine—Decreased appetite—Etoposide—sarcoma	0.000506	0.000668	CcSEcCtD
Sibutramine—Renal failure—Epirubicin—sarcoma	0.000503	0.000664	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Etoposide—sarcoma	0.000503	0.000663	CcSEcCtD
Sibutramine—Asthenia—Mitoxantrone—sarcoma	0.000502	0.000663	CcSEcCtD
Sibutramine—Neuropathy peripheral—Epirubicin—sarcoma	0.000502	0.000662	CcSEcCtD
Sibutramine—Stomatitis—Epirubicin—sarcoma	0.000499	0.000658	CcSEcCtD
Sibutramine—Pain—Etoposide—sarcoma	0.000498	0.000657	CcSEcCtD
Sibutramine—Constipation—Etoposide—sarcoma	0.000498	0.000657	CcSEcCtD
Sibutramine—Conjunctivitis—Epirubicin—sarcoma	0.000498	0.000656	CcSEcCtD
Sibutramine—Urinary tract infection—Epirubicin—sarcoma	0.000498	0.000656	CcSEcCtD
Sibutramine—Dysuria—Doxorubicin—sarcoma	0.000497	0.000655	CcSEcCtD
Sibutramine—Diarrhoea—Vincristine—sarcoma	0.000492	0.000649	CcSEcCtD
Sibutramine—Sweating—Epirubicin—sarcoma	0.000491	0.000647	CcSEcCtD
Sibutramine—Pollakiuria—Doxorubicin—sarcoma	0.000491	0.000647	CcSEcCtD
Sibutramine—Haematuria—Epirubicin—sarcoma	0.000488	0.000644	CcSEcCtD
Sibutramine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000485	0.00064	CcSEcCtD
Sibutramine—Weight increased—Doxorubicin—sarcoma	0.000483	0.000638	CcSEcCtD
Sibutramine—Epistaxis—Epirubicin—sarcoma	0.000483	0.000637	CcSEcCtD
Sibutramine—Nausea—Thiotepa—sarcoma	0.000482	0.000635	CcSEcCtD
Sibutramine—Sinusitis—Epirubicin—sarcoma	0.00048	0.000634	CcSEcCtD
Sibutramine—Feeling abnormal—Etoposide—sarcoma	0.00048	0.000633	CcSEcCtD
Sibutramine—Hyperglycaemia—Doxorubicin—sarcoma	0.000479	0.000632	CcSEcCtD
Sibutramine—Diarrhoea—Mitoxantrone—sarcoma	0.000479	0.000632	CcSEcCtD
Sibutramine—Nausea—Dactinomycin—sarcoma	0.000478	0.000631	CcSEcCtD
Sibutramine—Pneumonia—Doxorubicin—sarcoma	0.000476	0.000628	CcSEcCtD
Sibutramine—Gastrointestinal pain—Etoposide—sarcoma	0.000476	0.000628	CcSEcCtD
Sibutramine—Dizziness—Vincristine—sarcoma	0.000475	0.000627	CcSEcCtD
Sibutramine—Bradycardia—Epirubicin—sarcoma	0.000468	0.000617	CcSEcCtD
Sibutramine—Renal failure—Doxorubicin—sarcoma	0.000466	0.000614	CcSEcCtD
Sibutramine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000464	0.000612	CcSEcCtD
Sibutramine—Urticaria—Etoposide—sarcoma	0.000463	0.00061	CcSEcCtD
Sibutramine—Haemoglobin—Epirubicin—sarcoma	0.000462	0.000609	CcSEcCtD
Sibutramine—Stomatitis—Doxorubicin—sarcoma	0.000462	0.000609	CcSEcCtD
Sibutramine—Rhinitis—Epirubicin—sarcoma	0.000461	0.000608	CcSEcCtD
Sibutramine—Body temperature increased—Etoposide—sarcoma	0.00046	0.000607	CcSEcCtD
Sibutramine—Abdominal pain—Etoposide—sarcoma	0.00046	0.000607	CcSEcCtD
Sibutramine—Conjunctivitis—Doxorubicin—sarcoma	0.00046	0.000607	CcSEcCtD
Sibutramine—Urinary tract infection—Doxorubicin—sarcoma	0.00046	0.000607	CcSEcCtD
Sibutramine—Haemorrhage—Epirubicin—sarcoma	0.00046	0.000606	CcSEcCtD
Sibutramine—Hypoaesthesia—Epirubicin—sarcoma	0.000457	0.000603	CcSEcCtD
Sibutramine—Vomiting—Vincristine—sarcoma	0.000457	0.000603	CcSEcCtD
Sibutramine—Pharyngitis—Epirubicin—sarcoma	0.000456	0.000602	CcSEcCtD
Sibutramine—Sweating—Doxorubicin—sarcoma	0.000454	0.000599	CcSEcCtD
Sibutramine—Rash—Vincristine—sarcoma	0.000453	0.000598	CcSEcCtD
Sibutramine—Dermatitis—Vincristine—sarcoma	0.000453	0.000597	CcSEcCtD
Sibutramine—Oedema peripheral—Epirubicin—sarcoma	0.000453	0.000597	CcSEcCtD
Sibutramine—Haematuria—Doxorubicin—sarcoma	0.000452	0.000596	CcSEcCtD
Sibutramine—Headache—Vincristine—sarcoma	0.00045	0.000594	CcSEcCtD
Sibutramine—Epistaxis—Doxorubicin—sarcoma	0.000447	0.000589	CcSEcCtD
Sibutramine—Vomiting—Mitoxantrone—sarcoma	0.000445	0.000587	CcSEcCtD
Sibutramine—Sinusitis—Doxorubicin—sarcoma	0.000444	0.000586	CcSEcCtD
Sibutramine—Visual impairment—Epirubicin—sarcoma	0.000443	0.000584	CcSEcCtD
Sibutramine—Rash—Mitoxantrone—sarcoma	0.000442	0.000582	CcSEcCtD
Sibutramine—Dermatitis—Mitoxantrone—sarcoma	0.000441	0.000582	CcSEcCtD
Sibutramine—Headache—Mitoxantrone—sarcoma	0.000439	0.000579	CcSEcCtD
Sibutramine—Bradycardia—Doxorubicin—sarcoma	0.000433	0.000571	CcSEcCtD
Sibutramine—Eye disorder—Epirubicin—sarcoma	0.000429	0.000566	CcSEcCtD
Sibutramine—Hypersensitivity—Etoposide—sarcoma	0.000429	0.000566	CcSEcCtD
Sibutramine—Tinnitus—Epirubicin—sarcoma	0.000428	0.000565	CcSEcCtD
Sibutramine—Haemoglobin—Doxorubicin—sarcoma	0.000427	0.000564	CcSEcCtD
Sibutramine—Nausea—Vincristine—sarcoma	0.000427	0.000563	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—sarcoma	0.000426	0.000562	CcSEcCtD
Sibutramine—Haemorrhage—Doxorubicin—sarcoma	0.000425	0.000561	CcSEcCtD
Sibutramine—Hypoaesthesia—Doxorubicin—sarcoma	0.000423	0.000558	CcSEcCtD
Sibutramine—Pharyngitis—Doxorubicin—sarcoma	0.000422	0.000557	CcSEcCtD
Sibutramine—Oedema peripheral—Doxorubicin—sarcoma	0.000419	0.000553	CcSEcCtD
Sibutramine—Asthenia—Etoposide—sarcoma	0.000418	0.000551	CcSEcCtD
Sibutramine—Angiopathy—Epirubicin—sarcoma	0.000417	0.00055	CcSEcCtD
Sibutramine—Nausea—Mitoxantrone—sarcoma	0.000416	0.000549	CcSEcCtD
Sibutramine—Immune system disorder—Epirubicin—sarcoma	0.000415	0.000548	CcSEcCtD
Sibutramine—Chills—Epirubicin—sarcoma	0.000412	0.000544	CcSEcCtD
Sibutramine—Pruritus—Etoposide—sarcoma	0.000412	0.000544	CcSEcCtD
Sibutramine—Arrhythmia—Epirubicin—sarcoma	0.000411	0.000542	CcSEcCtD
Sibutramine—Visual impairment—Doxorubicin—sarcoma	0.00041	0.000541	CcSEcCtD
Sibutramine—Alopecia—Epirubicin—sarcoma	0.000406	0.000536	CcSEcCtD
Sibutramine—Malnutrition—Epirubicin—sarcoma	0.0004	0.000528	CcSEcCtD
Sibutramine—Diarrhoea—Etoposide—sarcoma	0.000399	0.000526	CcSEcCtD
Sibutramine—Eye disorder—Doxorubicin—sarcoma	0.000397	0.000524	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—sarcoma	0.000396	0.000523	CcSEcCtD
Sibutramine—Flatulence—Epirubicin—sarcoma	0.000394	0.00052	CcSEcCtD
Sibutramine—Tension—Epirubicin—sarcoma	0.000393	0.000518	CcSEcCtD
Sibutramine—Dysgeusia—Epirubicin—sarcoma	0.000392	0.000517	CcSEcCtD
Sibutramine—Nervousness—Epirubicin—sarcoma	0.000389	0.000513	CcSEcCtD
Sibutramine—Back pain—Epirubicin—sarcoma	0.000387	0.00051	CcSEcCtD
Sibutramine—Angiopathy—Doxorubicin—sarcoma	0.000386	0.000509	CcSEcCtD
Sibutramine—Dizziness—Etoposide—sarcoma	0.000385	0.000508	CcSEcCtD
Sibutramine—Muscle spasms—Epirubicin—sarcoma	0.000385	0.000507	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—sarcoma	0.000384	0.000507	CcSEcCtD
Sibutramine—Chills—Doxorubicin—sarcoma	0.000382	0.000503	CcSEcCtD
Sibutramine—Arrhythmia—Doxorubicin—sarcoma	0.00038	0.000501	CcSEcCtD
Sibutramine—Vision blurred—Epirubicin—sarcoma	0.000377	0.000497	CcSEcCtD
Sibutramine—Alopecia—Doxorubicin—sarcoma	0.000376	0.000496	CcSEcCtD
Sibutramine—Ill-defined disorder—Epirubicin—sarcoma	0.000371	0.00049	CcSEcCtD
Sibutramine—Vomiting—Etoposide—sarcoma	0.00037	0.000488	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—sarcoma	0.00037	0.000488	CcSEcCtD
Sibutramine—Anaemia—Epirubicin—sarcoma	0.00037	0.000488	CcSEcCtD
Sibutramine—Agitation—Epirubicin—sarcoma	0.000368	0.000485	CcSEcCtD
Sibutramine—Rash—Etoposide—sarcoma	0.000367	0.000484	CcSEcCtD
Sibutramine—Dermatitis—Etoposide—sarcoma	0.000367	0.000484	CcSEcCtD
Sibutramine—Headache—Etoposide—sarcoma	0.000365	0.000481	CcSEcCtD
Sibutramine—Flatulence—Doxorubicin—sarcoma	0.000365	0.000481	CcSEcCtD
Sibutramine—Tension—Doxorubicin—sarcoma	0.000363	0.000479	CcSEcCtD
Sibutramine—Dysgeusia—Doxorubicin—sarcoma	0.000362	0.000478	CcSEcCtD
Sibutramine—Malaise—Epirubicin—sarcoma	0.000361	0.000476	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—sarcoma	0.00036	0.000474	CcSEcCtD
Sibutramine—Vertigo—Epirubicin—sarcoma	0.000359	0.000474	CcSEcCtD
Sibutramine—Syncope—Epirubicin—sarcoma	0.000359	0.000473	CcSEcCtD
Sibutramine—Leukopenia—Epirubicin—sarcoma	0.000358	0.000472	CcSEcCtD
Sibutramine—Back pain—Doxorubicin—sarcoma	0.000358	0.000472	CcSEcCtD
Sibutramine—Muscle spasms—Doxorubicin—sarcoma	0.000356	0.000469	CcSEcCtD
Sibutramine—Palpitations—Epirubicin—sarcoma	0.000354	0.000466	CcSEcCtD
Sibutramine—Loss of consciousness—Epirubicin—sarcoma	0.000352	0.000464	CcSEcCtD
Sibutramine—Cough—Epirubicin—sarcoma	0.000349	0.00046	CcSEcCtD
Sibutramine—Vision blurred—Doxorubicin—sarcoma	0.000349	0.00046	CcSEcCtD
Sibutramine—Convulsion—Epirubicin—sarcoma	0.000347	0.000457	CcSEcCtD
Sibutramine—Nausea—Etoposide—sarcoma	0.000346	0.000456	CcSEcCtD
Sibutramine—Hypertension—Epirubicin—sarcoma	0.000345	0.000456	CcSEcCtD
Sibutramine—Ill-defined disorder—Doxorubicin—sarcoma	0.000343	0.000453	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—sarcoma	0.000342	0.000451	CcSEcCtD
Sibutramine—Chest pain—Epirubicin—sarcoma	0.000341	0.000449	CcSEcCtD
Sibutramine—Myalgia—Epirubicin—sarcoma	0.000341	0.000449	CcSEcCtD
Sibutramine—Arthralgia—Epirubicin—sarcoma	0.000341	0.000449	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—sarcoma	0.00034	0.000449	CcSEcCtD
Sibutramine—Anxiety—Epirubicin—sarcoma	0.000339	0.000448	CcSEcCtD
Sibutramine—Discomfort—Epirubicin—sarcoma	0.000337	0.000444	CcSEcCtD
Sibutramine—Malaise—Doxorubicin—sarcoma	0.000334	0.00044	CcSEcCtD
Sibutramine—Dry mouth—Epirubicin—sarcoma	0.000333	0.000439	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—sarcoma	0.000333	0.000439	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—sarcoma	0.000332	0.000438	CcSEcCtD
Sibutramine—Leukopenia—Doxorubicin—sarcoma	0.000331	0.000437	CcSEcCtD
Sibutramine—Confusional state—Epirubicin—sarcoma	0.000329	0.000434	CcSEcCtD
Sibutramine—Palpitations—Doxorubicin—sarcoma	0.000327	0.000431	CcSEcCtD
Sibutramine—Anaphylactic shock—Epirubicin—sarcoma	0.000326	0.000431	CcSEcCtD
Sibutramine—Oedema—Epirubicin—sarcoma	0.000326	0.000431	CcSEcCtD
Sibutramine—Loss of consciousness—Doxorubicin—sarcoma	0.000325	0.000429	CcSEcCtD
Sibutramine—Infection—Epirubicin—sarcoma	0.000324	0.000428	CcSEcCtD
Sibutramine—Cough—Doxorubicin—sarcoma	0.000323	0.000426	CcSEcCtD
Sibutramine—Shock—Epirubicin—sarcoma	0.000321	0.000424	CcSEcCtD
Sibutramine—Convulsion—Doxorubicin—sarcoma	0.000321	0.000423	CcSEcCtD
Sibutramine—Thrombocytopenia—Epirubicin—sarcoma	0.00032	0.000422	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—sarcoma	0.00032	0.000422	CcSEcCtD
Sibutramine—Tachycardia—Epirubicin—sarcoma	0.000319	0.00042	CcSEcCtD
Sibutramine—Skin disorder—Epirubicin—sarcoma	0.000317	0.000418	CcSEcCtD
Sibutramine—Hyperhidrosis—Epirubicin—sarcoma	0.000316	0.000416	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—sarcoma	0.000315	0.000416	CcSEcCtD
Sibutramine—Arthralgia—Doxorubicin—sarcoma	0.000315	0.000416	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—sarcoma	0.000315	0.000416	CcSEcCtD
Sibutramine—Anxiety—Doxorubicin—sarcoma	0.000314	0.000414	CcSEcCtD
Sibutramine—Discomfort—Doxorubicin—sarcoma	0.000311	0.000411	CcSEcCtD
Sibutramine—Anorexia—Epirubicin—sarcoma	0.000311	0.000411	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—sarcoma	0.000308	0.000407	CcSEcCtD
Sibutramine—Hypotension—Epirubicin—sarcoma	0.000305	0.000402	CcSEcCtD
Sibutramine—Confusional state—Doxorubicin—sarcoma	0.000305	0.000402	CcSEcCtD
Sibutramine—Anaphylactic shock—Doxorubicin—sarcoma	0.000302	0.000398	CcSEcCtD
Sibutramine—Oedema—Doxorubicin—sarcoma	0.000302	0.000398	CcSEcCtD
Sibutramine—Infection—Doxorubicin—sarcoma	0.0003	0.000396	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000297	0.000392	CcSEcCtD
Sibutramine—Shock—Doxorubicin—sarcoma	0.000297	0.000392	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—sarcoma	0.000296	0.00039	CcSEcCtD
Sibutramine—Insomnia—Epirubicin—sarcoma	0.000295	0.00039	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—sarcoma	0.000295	0.000389	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—sarcoma	0.000293	0.000387	CcSEcCtD
Sibutramine—Paraesthesia—Epirubicin—sarcoma	0.000293	0.000387	CcSEcCtD
Sibutramine—Hyperhidrosis—Doxorubicin—sarcoma	0.000292	0.000385	CcSEcCtD
Sibutramine—Dyspnoea—Epirubicin—sarcoma	0.000291	0.000384	CcSEcCtD
Sibutramine—Somnolence—Epirubicin—sarcoma	0.00029	0.000383	CcSEcCtD
Sibutramine—Anorexia—Doxorubicin—sarcoma	0.000288	0.00038	CcSEcCtD
Sibutramine—Dyspepsia—Epirubicin—sarcoma	0.000287	0.000379	CcSEcCtD
Sibutramine—Decreased appetite—Epirubicin—sarcoma	0.000284	0.000374	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—sarcoma	0.000282	0.000372	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000282	0.000372	CcSEcCtD
Sibutramine—Pain—Epirubicin—sarcoma	0.000279	0.000368	CcSEcCtD
Sibutramine—Constipation—Epirubicin—sarcoma	0.000279	0.000368	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000275	0.000363	CcSEcCtD
Sibutramine—Insomnia—Doxorubicin—sarcoma	0.000273	0.00036	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—sarcoma	0.000271	0.000358	CcSEcCtD
Sibutramine—Dyspnoea—Doxorubicin—sarcoma	0.000269	0.000355	CcSEcCtD
Sibutramine—Feeling abnormal—Epirubicin—sarcoma	0.000269	0.000355	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—sarcoma	0.000269	0.000354	CcSEcCtD
Sibutramine—Gastrointestinal pain—Epirubicin—sarcoma	0.000267	0.000352	CcSEcCtD
Sibutramine—Dyspepsia—Doxorubicin—sarcoma	0.000266	0.000351	CcSEcCtD
Sibutramine—Decreased appetite—Doxorubicin—sarcoma	0.000263	0.000346	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000261	0.000344	CcSEcCtD
Sibutramine—Urticaria—Epirubicin—sarcoma	0.000259	0.000342	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—sarcoma	0.000258	0.000341	CcSEcCtD
Sibutramine—Pain—Doxorubicin—sarcoma	0.000258	0.000341	CcSEcCtD
Sibutramine—Abdominal pain—Epirubicin—sarcoma	0.000258	0.00034	CcSEcCtD
Sibutramine—Body temperature increased—Epirubicin—sarcoma	0.000258	0.00034	CcSEcCtD
Sibutramine—Feeling abnormal—Doxorubicin—sarcoma	0.000249	0.000328	CcSEcCtD
Sibutramine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000247	0.000326	CcSEcCtD
Sibutramine—Hypersensitivity—Epirubicin—sarcoma	0.000241	0.000317	CcSEcCtD
Sibutramine—Urticaria—Doxorubicin—sarcoma	0.00024	0.000317	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—sarcoma	0.000239	0.000315	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—sarcoma	0.000239	0.000315	CcSEcCtD
Sibutramine—Asthenia—Epirubicin—sarcoma	0.000234	0.000309	CcSEcCtD
Sibutramine—Pruritus—Epirubicin—sarcoma	0.000231	0.000305	CcSEcCtD
Sibutramine—Diarrhoea—Epirubicin—sarcoma	0.000223	0.000295	CcSEcCtD
Sibutramine—Hypersensitivity—Doxorubicin—sarcoma	0.000223	0.000294	CcSEcCtD
Sibutramine—Asthenia—Doxorubicin—sarcoma	0.000217	0.000286	CcSEcCtD
Sibutramine—Dizziness—Epirubicin—sarcoma	0.000216	0.000285	CcSEcCtD
Sibutramine—Pruritus—Doxorubicin—sarcoma	0.000214	0.000282	CcSEcCtD
Sibutramine—Vomiting—Epirubicin—sarcoma	0.000208	0.000274	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—sarcoma	0.000207	0.000273	CcSEcCtD
Sibutramine—Rash—Epirubicin—sarcoma	0.000206	0.000272	CcSEcCtD
Sibutramine—Dermatitis—Epirubicin—sarcoma	0.000206	0.000271	CcSEcCtD
Sibutramine—Headache—Epirubicin—sarcoma	0.000205	0.00027	CcSEcCtD
Sibutramine—Dizziness—Doxorubicin—sarcoma	0.0002	0.000264	CcSEcCtD
Sibutramine—Nausea—Epirubicin—sarcoma	0.000194	0.000256	CcSEcCtD
Sibutramine—Vomiting—Doxorubicin—sarcoma	0.000192	0.000253	CcSEcCtD
Sibutramine—Rash—Doxorubicin—sarcoma	0.00019	0.000251	CcSEcCtD
Sibutramine—Dermatitis—Doxorubicin—sarcoma	0.00019	0.000251	CcSEcCtD
Sibutramine—Headache—Doxorubicin—sarcoma	0.000189	0.00025	CcSEcCtD
Sibutramine—Nausea—Doxorubicin—sarcoma	0.000179	0.000237	CcSEcCtD
